🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK1120212 is a potent and highly selective inhibitor of MEK phosphorylatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08
Trial ID
NCT01231581
Treatments Being Tested
This is a global, multi-centre, open-label, study of GSK2118436 conducted i...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-04-08
Trial ID
NCT01978236
Treatments Being Tested
The purpose of this Treatment Plan is to allow access to trametinib and dab...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04544202
Treatments Being Tested
Present clinical study will be conducted in China to evaluate the pharmacok...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05
Trial ID
NCT02447939
Treatments Being Tested
The purpose of this Cohort Treatment Plan is to allow access to trametinib ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04489433
Treatments Being Tested
The purpose of the this study is to evaluate the effect of a high-fat, high...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-02
Trial ID
NCT01371487
Treatments Being Tested
This was a two-arm, randomized, double-blind Phase III study of dabrafenib ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-01-08
Trial ID
NCT01682083
Treatments Being Tested
This is a multi-cohort, open label, Phase II study with Dabrafenib (GSK2118...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-21
Trial ID
NCT02039947
Treatments Being Tested
The purpose of this study was to investigate the activity of dabrafenib in ...
Status
Completed
Location
Children's Hospital of Orange County
Start Date
2017-12-28
Trial ID
NCT02684058
Treatments Being Tested
This is a single arm open label, multicenter, non randomized, access study ...
Status
No Longer Available
Location
GSK Investigational Site
Start Date
TBD
Trial ID
NCT02416232
Treatments Being Tested